Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1–infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275)
Titel:
Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1–infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275)
Auteur:
Nixon, Daniel E. Bosch, Ronald J. Chan, Ellen S. Funderburg, Nicholas T. Hodder, Sally Lake, Jordan E. Lederman, Michael M. Klingman, Karin L. Aberg, Judith A.